The role of the pharmacist as a member of the palliative care team

Progress in Palliative Care

Volumn 11, Issue 6, 2003, Pages 315-320

  Austwick, Elizabeth ^a   Brooks, David ^a  

^a CHESTERFIELD ROYAL HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; GENTAMICIN; LITHIUM; PHENYTOIN; THEOPHYLLINE;

CONTINUING EDUCATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG ADMINISTRATION ROUTE; DRUG COST; DRUG FORMULATION; DRUG INFORMATION; DRUG MECHANISM; DRUG MONITORING; DRUG SAFETY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MEDICOLEGAL ASPECT; PALLIATIVE THERAPY; PATIENT CARE; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PHARMACIST; POSTGRADUATE EDUCATION; PRESCRIPTION; PRIMARY MEDICAL CARE; RESPONSIBILITY; REVIEW; SAFETY; TEAMWORK;

EID: 1442302356     PISSN: 09699260     EISSN: None     Source Type: Journal    
DOI: 10.1179/096992603225003752     Document Type: Review

References (29)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
2. United Kingdom Clinical Pharmacists' Association. Statement on pharmaceutical care. London: UKCPA, 1996.
3. Burch PL, Hunter KA. Pharmaceutical care applied to the hospice setting: a cancer pain model. Hosp J 1996;11:55-69.
4. Keogh K, Jeffrey D, Flanagan S. The Palliative Care Education Group for Gloucestershire (PEGG): an integrated model of multidisciplinary education in palliative care. Eur J Cancer Care 1999;8:44-7.
5. Hearn J, Higginson IJ. Do specialist palliative care teams improve outcomes for cancer patients? Palliat Med 1998;12:317-31.
6. Jones EM. The support team: a multidisciplinary approach to terminal care. Palliative Care 1990 In: Modern Medicine Postgraduate Partwork Series: Caring at home for the dying patient. USA:Modern Medicine (© Edgell Communication Inc) 1990
7. Arter SG, Lipman AG. Hospice care: a new opportunity for pharmacists. J Pharm Practice 1990;3:28-33.
8. Ajemian I. The inter-disciplinary team. In: Doyle D, Hanks GWC, Macdonald N. (eds) Oxford Textbook of Palliative Medicine 2nd Edn. Oxford: Oxford University Press: 1998: 19-30.
9. Hanif N. Role of the palliative care unit pharmacist. J Palliat Care 1991;7(4):35-6.
10. Gilber P, Stefniuk K. The role of the pharmacist in palliative care: results of survey conducted in Australia and Canada. J Palliat Care 2002;18:287-92.
11. McQuillan R, Forbes K. The provision of a palliative care service in a teaching hospital and subsequent evaluation of that service. Palliat Med 1995;10:231-9.
12. Lucas C, Glare PA, Sykes JV. Contribution of a liaison pharmacist to an inpatient palliative care unit. Palliat Med 1997;11:209-16.
13. Twycross R, Wilcock A, Thorpe S, Dickman A. PCF2 Palliative Care Formulary. Oxford: Radcliffe Medical Press, 2002.
14. Anon. The Use of Drugs Beyond license in Palliative Care and Pain Management. A Position Statement prepared on behalf of the Association for Palliative Medicine and The Pain Society. London: Association for Palliative Medicine and The Pain Society, 2002.
15. Atkinson CV, Kirkham SR. Unlicenced uses for medication in a palliative care unit. Palliat Med 1999;13:145-52.
16. Pavis H, Willcock A. Prescribing of drugs for use outside their product licence in palliative care: a survey of specialists in the United Kingdom. BMJ 2001;323:484-5.
17. Snapp J, Kelley D, Gutsell TL. Creating a hospice pharmacy and therapeutics committee. Am J Hospice Palliat Care 2002;19:129-34.
18. Varga J. Guest editorial: a prescription for drug cost savings. Am J Hospice Palliat Care 2002;19:153.
19. Anon. NHS Funding of Independent Hospices 2001. Help the Hospices, Independent Representative committee. London: NHS, 2002.
20. http://www.doh.gov.uk/cancer/hospicefundingissues/.
21. Ishiguro T, Takahashi M, Kato H, Abe C, Shioya A, Ishiguro T et al. Role of pharmacists in the medical team - attempting palliative care. Gan to Kagaku Ryoho 1999;26 (Suppl 2):241-4.
22. Ahmedzai SH, Bennett M, Hardman C. Scientific evidence and expert opinion for the use of medications beyond their product license. In: Hillier R, Finlay I, Miles A. (eds) The Effective Management of Cancer Pain, 2nd edn. London: Aesculapius Medical Press, 2002.
23. Anon. Standards for the Administration of Medicines. London: United Kingdom Central Council for Nursing, Midwifery and Health Visiting, 1992.
24. Austwick EA. Discharge Medication Counselling by Pharmacists: Helping Patients to Make the Most of Their Medicines. MSc Project, University of Derby, 1999.
25. Whigham Jr WD, Roberts KB. Considerations when proposing consultant pharmacist services to hospice programs. Contemp Pharm Pract 1982;5:239-45.
26. Zeppetella G. How do terminally ill patients at home take their medication? Palliat Med 1999;13:469-75.
27. Royal Pharmaceutical Society of Great Britain. Working Party Report: From Compliance to Concordance. London: Royal Pharmaceutical Society of Great Britain, 1997.
28. Austwick EA, Brown LC, Goodyear KH, Brooks DJ. Pharmacist's input into a palliative care clinic. Pharm J 2002;268:404-6.
29. Needham DS, Wong ICK, Campion PD. Evaluation of the effectiveness of UK community pharmacists' interventions in community palliative care. Palliat Med 2002;16:219-25.